Find a UK-based prescribing clinician for medical cannabis.
NHS vs Private Medical Cannabis Prescriptions in the UK
Medical cannabis was legalised in the United Kingdom in November 2018, yet most patients who qualify still struggle to access it through the National Health Service. The result is a two-tier system: a small number of NHS prescriptions issued under highly restricted circumstances, and a rapidly growing private sector of specialist clinics that now serves the vast majority of UK medical cannabis patients. This guide explains how both pathways work, what they cost, and how to decide which route is right for you.
Before exploring each option, it helps to understand the broader framework. Under UK law, cannabis-based products for medicinal use (CBPMs) are Schedule 2 controlled drugs that can be prescribed by any specialist doctor who holds a licence to prescribe. The product must be a licensed medicine or, where no licensed option exists, an unlicensed CBPM authorised on a named-patient basis. Both NHS and private prescriptions operate within this same legal structure; what differs is the funding model, clinical pathway, and practical accessibility. For a full overview of the regulatory landscape, see our complete UK medical cannabis guide.
Can You Get Medical Cannabis on the NHS?
Technically, yes — but in practice, NHS prescriptions for medical cannabis remain exceptionally rare. NHS England confirmed as far back as 2019 that only a handful of patients had received funded prescriptions, and the situation has not changed dramatically since. The core obstacle is NHS England’s commissioning policy, which requires robust clinical evidence before funding a treatment. For most cannabis-based medicines, the evidence base — while growing — does not yet meet the threshold required by NHS appraisal bodies such as NICE (the National Institute for Health and Care Excellence).
This means that even if a specialist consultant is willing to prescribe, the NHS may refuse to fund the medication. Patients can be prescribed but left to pay out of pocket — which is functionally equivalent to going private without the benefit of a streamlined private-clinic process.
There are also structural barriers: NHS specialist waiting lists are long, many consultants lack experience with CBPMs, and hospital formularies often do not stock these products. In short, while the NHS route exists on paper, the realistic probability of receiving a funded medical cannabis prescription through the NHS remains very low for most conditions.
What Conditions Can Be Prescribed Medical Cannabis on the NHS?
The NICE guidelines and NHS England commissioning decisions currently support NHS-funded medical cannabis prescriptions in only three narrow clinical areas:
- Childhood epilepsy syndromes — specifically Dravet syndrome and Lennox-Gastaut syndrome, where Epidyolex (pharmaceutical-grade cannabidiol) is approved and NHS-funded following a positive NICE appraisal.
- Chemotherapy-induced nausea and vomiting (CINV) — Nabilone, a synthetic cannabinoid, has been available on the NHS for decades and is prescribed where other antiemetics have failed.
- Multiple sclerosis spasticity — Sativex (nabiximols) holds a marketing authorisation in the UK for MS spasticity, though NHS commissioning remains patchy and varies across devolved nations.
The British Paediatric Neurology Association (BPNA) has published specific guidance on cannabis-based medicines for children with epilepsy, reinforcing Epidyolex as the evidence-backed standard. For the vast majority of conditions treated in private clinics — chronic pain, anxiety disorders, PTSD, insomnia, fibromyalgia, and inflammatory conditions — there is currently no NHS pathway for funded prescriptions. Patients with these conditions must seek private care or remain without access to this treatment option.
How Private Medical Cannabis Clinics Work in the UK
The private medical cannabis sector in the UK has matured considerably since legalisation. Today, several well-established clinics operate legally, employing GMC-registered specialist doctors who prescribe CBPMs within the Schedule 2 framework. The process typically works as follows:
- Initial consultation — An online or in-person appointment with a specialist doctor. You will need to provide medical records, GP referral letters, or evidence of previous treatments attempted. The doctor assesses eligibility based on your condition, treatment history, and clinical need.
- Prescription issuance — If appropriate, the doctor issues a private prescription for a CBPM. This is a legally valid Schedule 2 prescription that must be dispensed by a pharmacy authorised to handle controlled drugs.
- Dispensing — The prescription is sent to a specialist dispensing pharmacy. Products are typically delivered to your home within a few days. Use our pharmacy finder to locate a dispensing pharmacy near you.
- Follow-up and titration — Clinics schedule regular follow-up appointments to monitor response, adjust dosing, and renew prescriptions. Monthly or quarterly reviews are standard practice.
Private clinics operate independently of NHS funding, which gives them greater flexibility to prescribe across a wider range of conditions and products. If you are looking for a specialist, our doctor finder lists GMC-registered prescribers across the UK.
Cost Comparison: NHS vs Private Prescription
Cost is one of the most significant practical differences between the two pathways. The table below provides a realistic comparison based on current market data.
| Factor | NHS | Private |
|---|---|---|
| Consultation fee | Free (if referred and funded) | £50 – £200 per appointment |
| Monthly medication cost | Standard NHS prescription charge (or exempt) | £150 – £600 per month typically |
| Wait time (first appointment) | Weeks to months via NHS specialist referral | Days to 1–2 weeks |
| Conditions covered | Extremely narrow — epilepsy, MS spasticity, CINV only in practice | Broad — chronic pain, PTSD, anxiety, insomnia, fibromyalgia, and more |
| Product flexibility | Very limited — licensed medicines only in most cases | Wide range including flower, oils, capsules, and vaporisers |
| Prescription renewal | Through NHS specialist (slow, uncertain) | Online follow-up — typically monthly or quarterly |
| GP involvement required | Yes — GP referral to specialist usually needed | No — clinics can assess independently |
For patients with conditions outside the NHS-funded categories, private care is not simply a faster option — it is often the only realistic option. Monthly costs vary significantly depending on the product, dosage, and clinic chosen. Some private clinics offer payment plans, and a small number of insurance providers are beginning to explore coverage for medical cannabis, though this remains uncommon.
Top Private Medical Cannabis Clinics in the UK
The UK private medical cannabis clinic sector is regulated and growing. The following clinics are among the most established and widely recognised:
Sapphire Medical Clinics
One of the largest and longest-established medical cannabis clinics in the UK, Sapphire operates across multiple locations and online. Known for its rigorous clinical standards and multi-disciplinary team approach, Sapphire was among the first clinics to open following legalisation and has treated thousands of patients across a wide range of conditions.
Releaf
Releaf is a digital-first clinic that has positioned itself as a high-volume, accessible option for UK patients. Its online-only model keeps consultation costs relatively low and allows patients from across the country to access specialist care without travelling. Releaf has been particularly active in treating chronic pain and mental health conditions.
Alternaleaf
Alternaleaf is part of the Montu Group, one of Australia’s largest medical cannabis companies, which has expanded into the UK market. The clinic combines an app-based patient experience with GMC-registered specialists and has rapidly grown its UK patient base. Alternaleaf is known for competitive pricing and a streamlined onboarding process.
Curaleaf Clinic
Curaleaf Clinic is the clinical arm of Curaleaf International, a global cannabis company with significant UK operations. The clinic benefits from Curaleaf’s supply chain and product range, offering patients access to a broad formulary. Curaleaf Clinic focuses on evidence-based prescribing across pain, neurology, and psychiatry.
Rokeby Medical
Rokeby Medical takes a more traditional specialist-clinic approach, with a strong emphasis on complex cases and patients who have tried multiple conventional treatments without success. The clinic works closely with GPs and other specialists, making it a particularly suitable option for patients with complicated medical histories who need a collaborative care approach.
The clinics listed above are among the most recognised in the sector. Patients are encouraged to research each clinic independently, verify GMC registration of prescribing doctors, and consider multiple options before committing. For a broader list of registered prescribers, visit our doctor finder. Healthcare professionals interested in partnering with Cannamedical Britannia can visit our clinicians hub.
Which Route Is Right for You?
The answer depends primarily on your diagnosis and medical history. If you or your child has Dravet syndrome, Lennox-Gastaut syndrome, MS spasticity, or chemotherapy-induced nausea and vomiting that has not responded to other treatments, the NHS route is worth pursuing. It is the only pathway that may result in funded treatment. Speak to your GP about a referral to a specialist with experience in CBPMs, and be prepared for a potentially lengthy process.
For the vast majority of patients — those with chronic pain, fibromyalgia, PTSD, anxiety disorders, insomnia, or other conditions not covered by current NHS commissioning decisions — the private route is the practical choice. Private clinics can typically see you within days, offer a wider range of products, and provide more responsive ongoing care.
Several practical considerations apply regardless of which route you take:
- Keep your GP informed. Even if you are accessing private care, your GP should be aware of your CBPM prescription. This is important for safety, drug interaction monitoring, and maintaining an accurate medical record.
- Verify the prescribing doctor’s credentials. Any doctor prescribing CBPMs privately must be GMC-registered and hold a relevant specialist qualification. Legitimate clinics make this information available.
- Use a licensed dispensing pharmacy. Medical cannabis must be dispensed by a pharmacy authorised to handle Schedule 2 controlled drugs. Our pharmacy finder can help you locate an authorised provider.
- Be cautious of guarantees. Legitimate clinics assess each patient individually. Any clinic that guarantees a prescription before clinical assessment should be treated with scepticism.
The UK medical cannabis landscape continues to evolve. NHS commissioning decisions may expand as the clinical evidence base grows, and the private sector continues to improve its standards and accessibility. Staying informed through authoritative sources — including NHS England, NICE, and the BPNA guidelines — is the best way to ensure you are accessing safe, legal, and effective care.
Medically reviewed by the Cannamedical Britannia Clinical Team, May 2026. This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any treatment.
